1. Home
  2. NXL vs HUBC Comparison

NXL vs HUBC Comparison

Compare NXL & HUBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • HUBC
  • Stock Information
  • Founded
  • NXL 2010
  • HUBC 2017
  • Country
  • NXL United States
  • HUBC Israel
  • Employees
  • NXL N/A
  • HUBC N/A
  • Industry
  • NXL Medical Specialities
  • HUBC
  • Sector
  • NXL Health Care
  • HUBC
  • Exchange
  • NXL Nasdaq
  • HUBC Nasdaq
  • Market Cap
  • NXL 21.0M
  • HUBC 21.7M
  • IPO Year
  • NXL 2022
  • HUBC N/A
  • Fundamental
  • Price
  • NXL $1.04
  • HUBC $2.25
  • Analyst Decision
  • NXL Strong Buy
  • HUBC
  • Analyst Count
  • NXL 1
  • HUBC 0
  • Target Price
  • NXL $5.00
  • HUBC N/A
  • AVG Volume (30 Days)
  • NXL 81.9K
  • HUBC 1.1M
  • Earning Date
  • NXL 08-07-2025
  • HUBC 05-01-2025
  • Dividend Yield
  • NXL N/A
  • HUBC N/A
  • EPS Growth
  • NXL N/A
  • HUBC N/A
  • EPS
  • NXL N/A
  • HUBC N/A
  • Revenue
  • NXL $131,065.00
  • HUBC $29,562,000.00
  • Revenue This Year
  • NXL $79.59
  • HUBC N/A
  • Revenue Next Year
  • NXL $334.65
  • HUBC N/A
  • P/E Ratio
  • NXL N/A
  • HUBC N/A
  • Revenue Growth
  • NXL N/A
  • HUBC N/A
  • 52 Week Low
  • NXL $0.59
  • HUBC $1.80
  • 52 Week High
  • NXL $4.49
  • HUBC $14.00
  • Technical
  • Relative Strength Index (RSI)
  • NXL 29.65
  • HUBC 45.31
  • Support Level
  • NXL $1.12
  • HUBC $1.80
  • Resistance Level
  • NXL $1.30
  • HUBC $2.57
  • Average True Range (ATR)
  • NXL 0.09
  • HUBC 0.25
  • MACD
  • NXL 0.00
  • HUBC 0.02
  • Stochastic Oscillator
  • NXL 0.00
  • HUBC 58.44

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

Share on Social Networks: